18-F-FLT-PET for response evaluation of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with solid tumors.
Publication year
2012Source
World Journal of Nuclear Medicine, 2012, 11, (2012), pp. 65-67ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Medical Oncology
Pulmonary Diseases
Nuclear Medicine
Journal title
World Journal of Nuclear Medicine
Volume
vol. 2012
Issue
iss. 11
Page start
p. 65
Page end
p. 67
Subject
NCMLS 2: Immune Regulation ONCOL 3: Translational research; ONCOL 2: Age-related aspects of cancer; ONCOL 2: Age-related aspects of cancer NCEBP 4: Quality of hospital and integrated care; ONCOL 3: Translational research; ONCOL 3: Translational research N4i 1: Pathogenesis and modulation of inflammation; ONCOL 5: Aetiology, screening and detection; Medical Imaging - Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [243984]
- Electronic publications [130695]
- Faculty of Medical Sciences [92811]
- Open Access publications [104974]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.